Dmitry Balyasny’s Transmedics TMDX Stock Holding History

Dmitry Balyasny’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,000	Closed	-$852K	–	3529
2025 Q4	$852K	Buy	+7,000	New	+$878K	﹤0.01%	2266
2025 Q3	–	Sell	-8,100	Closed	-$1.09M	–	3473
2025 Q2	$1.09M	Buy	+8,100	New	+$889K	﹤0.01%	2013

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dmitry Balyasny's TMDX Position: Q4 2025 in Review

Dmitry Balyasny sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 54,305 shares — an estimated $6.81M sold.

Dmitry Balyasny first reported a position in TMDX in Q4 2022 and held it in 4 quarters. The position peaked at $6.09M in Q3 2025. 429 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Dmitry Balyasny reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Dmitry Balyasny sold 54,305 Transmedics shares in Q4 2025, an estimated $6.81M.
Dmitry Balyasny first reported a position in Transmedics in Q4 2022 and held it in 4 quarters.
Dmitry Balyasny's Transmedics position peaked at $6.09M in Q3 2025.
429 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.